# Evaluation of Probiotic (L.Reuteri) Survival in Presence of Prebiotic Galacto-oligosaccharides

> **NCT05555004** · NA · TERMINATED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** TEST1
- **OTHER:** TEST 2

## Key facts

- **NCT ID:** NCT05555004
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-30
- **Primary completion:** 2023-04-06
- **Final completion:** 2023-04-06
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Based on slow recruitement and Interim analysis recommendation, the core team decide to stop the study
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05555004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05555004, "Evaluation of Probiotic (L.Reuteri) Survival in Presence of Prebiotic Galacto-oligosaccharides". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05555004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*